Article: CryoCor Confirms FDA Advisory Panel Meeting.

- AF Pivotal Trial Enrollment On Track -

SAN DIEGO, June 19 /PRNewswire-FirstCall/ -- CryoCor, Inc. , a medical device company focused on the treatment of cardiac arrhythmias, today provided an update on its clinical progress.

The Company reiterated that it is scheduled to present on June 27, 2007 clinical data related to its pre market approval, or PMA, application for the treatment of atrial flutter, or AFL, at an Advisory Panel meeting. The United States Food and Drug Administration, or FDA, will convene the Advisory Panel meeting to advise the FDA on whether or not the chronic effectiveness data in CryoCor's pivotal trial for the treatment of AFL ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!